02.11.2018
- Paolo Magri, senior vice president, business development at Advitech, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT). Also elected to...
31.10.2018
- A US federal appeals court has rejected an appeal by Danish biopharma Forward Pharma against the validity of Biogen’s patent for blockbuster multiple sclerosis (MS) drug Tecfidera...
22.10.2018
- French drugmaker Sanofi is planning to deepen the rare diseases footprint of its Genzyme franchise at Cambridge, Massachusetts, US, where according to reports the business could...
10.04.2018
- Biogen and partner Samsung Bioepis have reached agreement with AbbVie regarding the commercialization of Imraldi, their biosimilar form of the latter’s blockbuster Humira. Specific...
19.05.2017
- Biogen has licensed a late-stage stroke drug from Remedy Pharmaceuticals. The US biotech will make an upfront payment of $120 million for Cirara (intravenous glyburide), as well as...
03.06.2016
- Biogen’s investigational treatment for early Alzheimer’s disease (AD), aducanumab, has been accepted into the European Medicines Agency’s (EMA) PRIority MEdicines (PRIME) program...
20.05.2016
- US biotechnology company Biogen is to spin off its hemophilia business into an independent, publicly traded business. Biogen said it believes the creation of two separate companies...
24.02.2016
- Major drugs firms AstraZeneca, Pfizer and Eli Lilly are among seven of the world’s largest pharmaceutical companies that have joined a new consortium to improve clinical trials for...
